Hybrid nutraceutical of 2-ketoglutaric acid in improving inflammatory bowel disease: Role of prebiotics and TAK1 inhibitor
Authors:
Open Access
- 20 January 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 171, 116126
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
- Ministry of Science and ICT, South Korea (NRF-2021R1A2C3011051)
- Ministry of Education (2022M3A9I5018286)
- Ministry of Education (2022R1A2C1010923)
This publication has 48 references indexed in Scilit:
- Dextran Sulfate Sodium (DSS)‐Induced Colitis in MiceCurrent Protocols in Immunology, 2014
- Intestinal barrier function in health and gastrointestinal diseaseNeurogastroenterology & Motility, 2012
- Determination of organic acids in fruits and vegetables by liquid chromatography with tandem-mass spectrometryFood Chemistry, 2012
- Relationships between arthropod richness, evenness, and diversity are altered by complementarity among plant genotypesOecologia, 2011
- Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1Cancer Prevention Research, 2011
- UniFrac: an effective distance metric for microbial community comparisonThe ISME Journal, 2010
- Target identification using drug affinity responsive target stability (DARTS)Proceedings of the National Academy of Sciences, 2009
- Inhibitory Effect of Recombinant IL-25 on the Development of Dextran Sulfate Sodium-Induced Experimental Colitis in MiceCellular & Molecular Immunology, 2008
- Myricetin Suppresses UVB-Induced Skin Cancer by Targeting FynCancer Research, 2008
- Quantitation of Nine Organic Acids in Wild MushroomsJournal of Agricultural and Food Chemistry, 2005